Medicines360 Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Medicines360's estimated annual revenue is currently $9.6M per year.(i)
  • Medicines360's estimated revenue per employee is $201,000

Employee Data

  • Medicines360 has 48 Employees.(i)
  • Medicines360 grew their employee count by -19% last year.

Medicines360's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP, Policy and Strategic Market AccessReveal Email/Phone
3
VP, Strategic DevelopmentReveal Email/Phone
4
VP Product DevelopmentReveal Email/Phone
5
VP, Finance & AccountingReveal Email/Phone
6
SVP, Quality and Product SafetyReveal Email/Phone
7
VP Commercial and Business DevelopmentReveal Email/Phone
8
Director Corporate AffairsReveal Email/Phone
9
Director Regulatory AffairsReveal Email/Phone
10
Senior Director, Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$102.7M51125%N/AN/A
#2
$0.4M20%N/AN/A
#3
$38.6M1923%N/AN/A
#4
$35M1272%$62.5MN/A
#5
$36.6M18218%N/AN/A
#6
$131.9M656-3%N/AN/A
#7
$133.5M664N/AN/AN/A
#8
$72.8M362-4%N/AN/A
#9
$551.9M1716-2%N/AN/A
#10
$11.7M5812%N/AN/A
Add Company

What Is Medicines360?

Medicines360 is a non-profit pharmaceutical company and social enterprise working toward self-sustainability through commercial sales revenue that develops innovative, affordable, and sustainable medical solutions for women. Profit is a means of achieving our mission, not our motive; we exist to meet the medical needs of all women.

keywords:N/A

N/A

Total Funding

48

Number of Employees

$9.6M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medicines360 News

2022-04-17 - Global Intrauterine Contraceptive Devices (IUCD) Market ...

... (IUCD) Market 2022 Growth Statistics by Key Vendors – Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M48-4%$162.2M
#2
$5.1M48-56%$115.3M
#3
$6.7M48-29%N/A
#4
$7.4M480%$83M
#5
$4.7M48-6%$10M